Based on the dataset from TCGA 30, samples with YWHAZ genetic gain/amplification tended to also express higher mRNA (by RNA seq) and protein (by RPPA; reverse phase protein arrays) levels in their cancer tissues (p = 0.013) (Figure 2A). The gene discussed is YWHAZ; the disease is cancer.